1. Home
  2. KLTO vs AMZE Comparison

KLTO vs AMZE Comparison

Compare KLTO & AMZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTO
  • AMZE
  • Stock Information
  • Founded
  • KLTO 2019
  • AMZE 2019
  • Country
  • KLTO United States
  • AMZE United States
  • Employees
  • KLTO N/A
  • AMZE N/A
  • Industry
  • KLTO
  • AMZE Beverages (Production/Distribution)
  • Sector
  • KLTO
  • AMZE Consumer Staples
  • Exchange
  • KLTO NYSE
  • AMZE Nasdaq
  • Market Cap
  • KLTO 7.1M
  • AMZE 6.6M
  • IPO Year
  • KLTO N/A
  • AMZE 2021
  • Fundamental
  • Price
  • KLTO $0.21
  • AMZE $0.30
  • Analyst Decision
  • KLTO
  • AMZE
  • Analyst Count
  • KLTO 0
  • AMZE 0
  • Target Price
  • KLTO N/A
  • AMZE N/A
  • AVG Volume (30 Days)
  • KLTO 35.4M
  • AMZE 127.5K
  • Earning Date
  • KLTO 05-15-2025
  • AMZE 05-20-2025
  • Dividend Yield
  • KLTO N/A
  • AMZE N/A
  • EPS Growth
  • KLTO N/A
  • AMZE N/A
  • EPS
  • KLTO N/A
  • AMZE N/A
  • Revenue
  • KLTO N/A
  • AMZE $254,711.00
  • Revenue This Year
  • KLTO N/A
  • AMZE N/A
  • Revenue Next Year
  • KLTO N/A
  • AMZE N/A
  • P/E Ratio
  • KLTO N/A
  • AMZE N/A
  • Revenue Growth
  • KLTO N/A
  • AMZE N/A
  • 52 Week Low
  • KLTO $0.11
  • AMZE $0.25
  • 52 Week High
  • KLTO $0.99
  • AMZE $1.25
  • Technical
  • Relative Strength Index (RSI)
  • KLTO N/A
  • AMZE N/A
  • Support Level
  • KLTO N/A
  • AMZE N/A
  • Resistance Level
  • KLTO N/A
  • AMZE N/A
  • Average True Range (ATR)
  • KLTO 0.00
  • AMZE 0.00
  • MACD
  • KLTO 0.00
  • AMZE 0.00
  • Stochastic Oscillator
  • KLTO 0.00
  • AMZE 0.00

About KLTO KLOTHO NEUROSCIENCES INC

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

About AMZE Amaze Holdings Inc. Common Stock

Amaze Holdings Inc is engaged in producer of low carb, low calorie, premium wines in the United States. The company offers bold, crisp, and creamy wines that embody health, warmth, and a deeper connection to wellness and an active lifestyle. The company currently sell seven proprietary varietals: Cabernet Sauvignon, Pinot Noir, Chardonnay, Sauvignon Blanc, Rose, Sparkling Rose, and a limited Reserve Napa Cabernet Sauvignon.

Share on Social Networks: